Table 4 Perceptions of community pharmacists towards pharmacogenomics services
Variables | Frequency (%) | ||||
|---|---|---|---|---|---|
Strongly agree | Agree | Neutral | Disagree | Strongly disagree | |
Community pharmacists are well-placed within the healthcare system to provide pharmacogenomics services | 29 (18.0) | 31 (19.3) | 29 (18.0) | 31 (19.3) | 40 (24.8) |
Pharmacogenomics testing services is feasible in community pharmacy setting | 34 (21.1) | 36 (22.4) | 38 (23.6) | 40 (24.8) | 12 (7.5) |
Community pharmacists have the expertise to interpret and adjust medication doses based on patient’s pharmacogenomics results | 36 (22.4) | 50 (31.1) | 42 (26.1) | 12 (7.5) | 20 (12.4) |
Community pharmacists need training in pharmacogenomics | 91 (56.5) | 50 (31.1) | 14 (8.7) | 2 (1.2) | 1 (0.6) |
Physicians and community pharmacists should collaborate to offer pharmacogenomics testing | 103 (64.0) | 49 (30.4) | 6 (3.7) | 2 (1.2) | Â |
Pharmacogenomics testing will prevent your patient from taking the inappropriate medicine or the wrong dose | 97 (60.2) | 49 (30.4) | 11 (6.8) | 2 (1.2) | 1 (0.6) |
Incorporation of pharmacogenetic screening into medication therapy management will optimize pharmacotherapy | 65 (40.4) | 75 (46.6) | 15 (9.3) | 3 (1.9) | Â |
Pharmacogenomics testing will become a routine in clinical practice in the future | 54 (33.5) | 43 (26.7) | 31 (19.3) | 26 (16.1) | 5 (3.1) |
Pharmacogenomics-guided treatment is cost-effective | 40 (24.8) | 68 (42.2) | 29 (18.0) | 7 (4.3) | 11 (6.8) |
Barriers to implementation of pharmacogenomics services | |||||
 Lack of knowledge | 86 (53.4) | 58 (36.0) | 8 (5.0) | 2 (1.2) | 2 (1.2) |
 Lack of reimbursement | 71 (44.1) | 60 (37.3) | 16 (9.9) | 5 (3.1) | 2 (1.2) |
 Lack of time | 63 (39.1) | 53 (32.9) | 25 (15.5) | 10 (6.2) | 3 (1.9) |
 Lack of guidelines | 82 (50.9) | 59 (36.6) | 8 (5.0) | 5 (3.1) | 1 (0.6) |
 Ethical considerations regarding ownership of genetic data | 77 (47.8) | 44 (27.3) | 28 (17.4) | 2 (1.2) | 3 (1.9) |
 Resistance from other healthcare professionals | 74 (46.0) | 52 (32.3) | 24 (14.9) | 4 (2.5) | 1 (0.6) |
 Lack of acceptance by patients | 78 (48.4) | 40 (24.8) | 22 (13.7) | 8 (5.0) | 7 (4.3) |